celastrol has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cowley, G; Czaplinski, JT; Demetri, GD; Eilers, G; Fletcher, JA; Jonker, AH; Luo, B; Mariño-Enríquez, A; Mayeda, M; Okamoto, M; Ou, WB; Root, DE; Sicinska, E; Taguchi, T; Wang, Y | 1 |
1 other study(ies) available for celastrol and Gastrointestinal Stromal Neoplasm
Article | Year |
---|---|
Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chaperonins; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Library; HSP90 Heat-Shock Proteins; Humans; Lentivirus; Oncogenes; Pentacyclic Triterpenes; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; RNA, Small Interfering; Triterpenes | 2014 |